NAMSW
NewAmsterdam Pharma Company N.V. Warrant
stockNASDAQWarrant
At CloseOct 16, 2026 10:37:43 AM EDT
8.82USD-41.744%(-6.32)1,932
NAMSW Financials
In Q2 FY 2026 (ended ), NewAmsterdam Pharma Company N.V. Warrant (NAMSW) reported revenue of $3.7M, net income of −$64.14M, operating cash flow of −$39.21M, and assets of $704.45M.
Loading financial statements…